Development of a production process for a novel nanofiber material for mAb purification

Important results from the project

The overall objective of the project was to develop a biological process for the production of a protein nanofiber-based functional biomaterials for use in the purification of monoclonal antibody drugs, patented the product and the biological production of the material, and to initiate the process to form a company with the aim to introduce the developed product on to the world market within this company.

Expected long term effects

All project objectives within the project except the one to introduce the developed new product on the world market within a newly formed company were achieved. The reason for why the process of introducing the product on to the world market failed was the fact that a competing product that had significantly better chemical properties and higher binding capacity than the new product developed within the project was launched by a larger company that is world leader in this product niche.

Approach and implementation

The design of and the development of a production system for the developed product is estimated to be very well implemented and a high level of achievement within this part of the project was reached. However, it can now afterwards be clearly seen that contact should have been made at an much early stage of the project with companies that could be a potential buyers or licensors of the manufactured product to ensure a development of product that would suit the company’s needs and product portfolio better.